2013 - CTS 2013 Congress


This page contains exclusive content for the member of the following sections: TTS, CTS. Log in to view.

Oral Communications 8

16.6 - Betain supplement enhances skeletal muscle differentiation in murine myoblasts via IGF-1 signaling activation

Presenter: Ileana , Terruzzi, Milan, Italy
Authors: Pamela Senesi1,2,3, Livio Luzi1,2,3, Anna Montesano1,2,3, Nausicaa Mazzocchi1,2,3, lleana Terruzzi1,2,3

Betain supplement enhances skeletal muscle differentiation in murine myoblasts via IGF-1 signaling activation

Pamela Senesi1,2,3, Livio Luzi1,2,3, Anna Montesano1,2,3, Nausicaa Mazzocchi1,2,3, lleana Terruzzi1,2,3

1Department of Biomedical Sciences for Health , University of Milan, Milan, Italy; 2Research Centre, San Donato Hospital and Scientific Institute, San Donato Hospital and Scientific Institute, Milan, Italy; 3Nutrition-Metabolism Unit, San Raffaele Scientific Institute, Milan, Italy

Betaine (BET) is a component of many food, including spinach and wheat. It is an essential osmolyte and a source of methyl groups. Recent studies have hypothesized that BET might play a role on athleticperformance. However, BET effects on skeletal muscle differentiation and hypertrophy remain not completely known.
In this study, we examined BET action on neo myotubes maturation and myogenesis, using C2C12 murine myoblastic cells. By dose-response study, we determined that 10 mM BET was the dose able to stimulate morphological changes and hypertrophic process in neo myotubes. Using RT2-PCR array strategy to identify the expression profile of genes, encoding proteins involved in IGF-1 pathway, we found that 10 mM BET could promote IGF-1 receptor (IGF-1 R) expression. Western blot and immunofluorescence analysis pointed out that, in neo myotubes, 10 mM BET improved not only IGF-1 signaling, but also the synthesis of Myosin Heavy Chain (MyHC), the major skeletal muscle marker. Moreover, 10 mM BET increased neo myotubes length.
In addition, we investigated BET role on myoblasts proliferation and differentiation. During proliferation, BET did not modify C2C12 proliferative rate, but promotedmyogenic induction, enhancing MyoD protein content and cellular elongation. During differentiation, BET raised muscle-specific markers and IGF-1 R protein levels.
These findings provide the first evidence that BET could promote muscle differentiation and myotubes size by IGF-1 pathway activation, indicating that BET might represent a possible new drug/integrator strategy, not only in sport performance but also in clinical conditions characterized by muscle function injury.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada